Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hematology-Oncology

“Biogen Idec Inc said on Wednesday its experimental treatment for patients with hemophilia A, a disorder that inhibits coagulation of the blood, controlled bleeding with fewer treatments in a late-stage clinical trial. About 30 percent of patients...
A new study in Cell investigates the role microRNAs play in controlling the hematopoietic injury response. Researchers treated a bone marrow transplant model with 5-fluorouracil and found, “Overexpression of screen-candidate miR-150 resulted in...
Researchers have developed a means to treat sickle cell anemia through bone marrow transplantation that does not require completely HLA-matched donors or the use of myeloblative procedures. The research, published in the journal Blood, discusses a new...